| RFA-AG-22-018—Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed) Applications are due on 10/28/2021 NOT-AR-21-006—Notice of Special Interest: Promoting Research on Mechanisms of Pathogenesis and Pathophysiology of Atypical Femoral Fracture (AFF) and Osteonecrosis of the Jaw (ONJ) This Notice is active through 7/18/2023; standard R01 and R21 due dates apply These funding opportunities respond to the research gaps and recommendations highlighted during the 2018 NIH Pathways to Prevention Workshop: Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention. Workshop resources, including the video recordings, systematic evidence review, independent panel’s final report, and federal partners’ action plan are available on the Office of Disease Prevention website. |